Patent Trial and Appeal Board

Our lawyers have been pioneering trial practice at the Patent Trial and Appeal Board (PTAB) since its first minutes of operation on September 16, 2012, filing multiple petitions early that morning, and have appeared continuously before the PTAB in more than 190 high-stakes Inter Partes Reviews (IPRs), Post Grant Reviews (PGRs), and Covered Business Method (CBM) reviews on behalf of both petitioners and patent owners. We also have extensive experience in Ex Parte Reexaminations. Exemplary matters include representing:

  • Liberty Mutual Insurance Company in filing ten petitions for CBM review, beginning the first day PTAB trials became available, resulting in final written PTAB decisions invalidating every claim of each challenged patent, all affirmed on appeal.
  • SAP AG as co-counsel in the first-ever CBM trial before the PTAB, resulting in the PTAB’s first final decision, in SAP’s favor and affirmed on appeal.
  • Amgen against biosimilar applicants in defending against multiple IPR challenges.
  • Simmons Bedding Company against Leggett & Platt in three IPR proceedings involving mattress technology.
  • A leading U.S. consumer electronics company in pursuing more than 40 CBM petitions relating to sale of digital content over the Internet that together invalidated every one of 150 litigated claims in seven patents that had led to a $533 million district court jury verdict.
  • Spansion LLC against Macronix in defending against eight IPR challenges involving semiconductors and memory technology.
  • Chugai Pharmaceuticals against Pfizer in IPR proceedings regarding protein purification.
  • Genentech in multiple matters defending against IPR challengers.
  • Twitter against Blackberry in IPR proceedings.
  • Twitter against PARC in IPR proceedings.
  • IP Bridge in defending two patents involving a method for forming an interconnection structure in a semiconductor integrated circuit in PTAB proceedings, including on appeal.
  • Nevro Corporation in successful defense of a pioneering patent relating to high-frequency spinal cord stimulation for inhibiting pain.